NEW YORK (GenomeWeb) – Bayer HealthCare today announced it has expanded a drug development collaboration with the Broad Institute to include cardiovascular genomics. 

As part of the expanded deal, Bayer and the Broad will collaborate on genetic discovery, target identification, and drug discovery activities. A joint steering committee and joint research committee will oversee research progress and direction, Bayer said. Financial and other terms of the deal were not disclosed. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.